Companies, Hospitals Line Up As FDA Device Center Training Sites
This article was originally published in The Gray Sheet
Executive Summary
More than 30 medical device-makers and clinical sites extended onsite invites to CDRH staffers to learn more about a wide array of industry topics, including neurointerventional device issues, male condom manufacturing, product reprocessing and sterilization methods.
You may also be interested in...
FDA Asks For More Industry Help To Train Staff
CDRH is asking for another round of volunteers to allow officials to visit manufacturing and clinical facilities to get first-hand perspective of how they operate as part of the center's Experimental Learning Program.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.